IMAX Attracts Strong Institutional Interest Amid Market Activity Institutional investors, including Thrivent Financial, have been actively adjusting their IMAX holdings. Thrivent reduced its stake by 33.1% in Q4, while other firms like FMR LLC significantly increased theirs. Analysts continue to view IMAX favorably, with an average price target of $30.67 and a consensus Buy rating.3